Clinical Report: Resveratrol and Diabetic Retinopathy

Overview

This systematic review highlights the potential of resveratrol as a multi-target modulator in early diabetic retinopathy (DR). Resveratrol demonstrates protective effects on mitochondrial health, inflammation, and the blood-retinal barrier, suggesting it may modify early DR progression.

Background

Diabetic retinopathy (DR) is a leading cause of vision loss among diabetic patients, with current treatments primarily addressing advanced stages of the disease. There is a critical need for preventive strategies that target early neuroinflammatory and metabolic disturbances. Resveratrol, a naturally occurring polyphenol, has emerged as a potential candidate for modulating these early pathological processes.

Data Highlights

Key Findings

Clinical Implications

{'issues': 'Expand on bioavailability and delivery methods as critical challenges.'}

Conclusion

The findings from this review underscore the importance of exploring upstream interventions in diabetic retinopathy management, particularly those targeting neuroinflammation and mitochondrial dysfunction.

References

1. Asanad, S., Retinal Physician, 2025 -- Dietary Nutrients and Diabetic Retinopathy
2. Bhavsar, A. R., Retinal Physician, 2004 -- Landmark Laser Trials Continue to Govern Standard of Care in Diabetic Retinopathy
3. ADA, PubMed, 2026 -- Standards of Care in Diabetes-2026
4. Retinal Physician — Dietary Nutrients and Diabetic Retinopathy
5. Retinal Physician — Clinical Trials Provide Rationale for Use of Anti-VEGF Treatment Earlier in Diabetic Retinopathy
6. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2026 - PubMed
7. Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials - PubMed